Speakers
Antony Mattesich
Chief Executive Officer
Amphista
Dan Elbaum
Chief Scientific Officer
QurAlis
David Donabedian
Executive Partner
Longwood Fund
Eliseo Salinas
Head of Research & Development
Delix
Jenny Laird
Vice President, Search & Evaluation Neuroscience
Eli Lilly
John Mayfield
Senior Vice President, Business Development & Strategy
Flagship Pioneering
Jonathan Levenson
Chief Scientific Officer
FireCyte Therapeutics
Laxminarayan Bhat
Founder, President & Chief Executive Officer
Reviva Pharma
Maria Maccecchini
Founder, President & CEO
Annovis
Mathias Schmidt
CEO | Executive Fellow
ArmaGen | JCR Pharmaceuticals
Michaela Tolman
Senior Director, Pipeline Strategic Planning
Pfizer
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy
AbbVie
Sam Alworth
Co-Founder & Chief Executive Officer
AcuraStem
Shaheen Lakhan
Chief Medical Officer
Click Therapeutics
Stacie Weninger
President
FBRI
Vidya Nadar
Director, Search & Evaluation, Rare & Neurological Disorders
Sanofi
Neel Desai
Executive Director, Business Development
Biogen
Alan Fu
CFO
IASO Biotechnology
Irena Melnikova
Partner
Pfizer Ventures
Catherine Abbadie
External Innovation Lead
Biogen
Sam Banister
Co-founder & Chief Scientific Officer
Xylo Bio
Doug Drysdale
Chief Executive Officer
Cybin
Hong Chen
Director, Search & Evaluation
Novo Nordisk
Raymond Houck
Chief Executive Officer
Aclipse Therapeutics
Rakhee Ganti
Founder & Chief Executive Officer
Dimer Pharmaceuticals
Navin Swaroop
Executive Director, Business Development
EMD Serono
Marcel van der Brug
Chief Scientific Officer
AcuraStem